Increased maternal mortality during the SARS-CoV-2 pandemic in Peru. A systematic review.

Descripción del Articulo

Introduction: The present study explored maternal mortality during the COVID-19 pandemic, with a specific focus on pregnant women with COVID-19. Material and methods: After registration of the research protocol in PROSPERO (CRD42024506108), a review of studies during the period January 2020 to Decem...

Descripción completa

Detalles Bibliográficos
Autores: Flores Limo, Gloria Yesenia, Fernández Martínez, Mónica Patricia
Formato: artículo
Fecha de Publicación:2024
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2404
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2404
Nivel de acceso:acceso abierto
Materia:Gestantes
Mortalidad
COVID-19
Perú
Pregnant women
Mortality
Peru
Descripción
Sumario:Introduction: The present study explored maternal mortality during the COVID-19 pandemic, with a specific focus on pregnant women with COVID-19. Material and methods: After registration of the research protocol in PROSPERO (CRD42024506108), a review of studies during the period January 2020 to December 2023 was conducted in PubMed, Scopus, Ovid, Web of Science, Google Scholar, Virtual Health Library, and Scielo databases using an advanced search and using terms such as ['COVID-19' AND ('pregnancy' OR 'pregnant') AND (Peru)]. Studies reporting maternal mortality due to COVID-19 were included. In addition, the results were compared with epidemiological reports proposed by the Peruvian Ministry of Health (MINSA). Results: Six studies with 44 pregnant women who died from COVID-19 were included. The studies covered four regions of Peru (Lima, Cajamarca, Huancayo, and Callao). Significant maternal complications were observed, including pre-eclampsia, eclampsia, prematurity, intrauterine growth restriction, and fetal death. Among the most frequent comorbidities were hypertension, diabetes, and obesity. According to MINSA epidemiological data, a total of 1,486 pregnant women were reported to have died between 2020 and 2023. Of these, 15.1% (n = 224) of deaths were directly attributed to COVID-19. Conclusions: COVID-19 represents a significant risk for pregnant women in Peru, with deaths attributed to the disease and severe maternal complications such as pre-eclampsia and prematurity, highlighting the need for maternal health care during the pandemic. It is essential that health authorities protect pregnant women from COVID-19 through vaccination, education on preventive measures, and specialized monitoring, especially for those with comorbidities.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).